Results 161 to 170 of about 1,776 (189)
Some of the next articles are maybe not open access.
A pretargeting approach to PET imaging with antibodies
Nuclear Medicine and Biology, 2022Pamela Penawou +5 more
openaire +1 more source
Journal of the American Chemical Society
Covalent modification of cell membranes has shown promise for tumor imaging and therapy. However, existing membrane labeling techniques face challenges such as slow kinetics and poor selectivity for cancer cells, leading to off-target effects and suboptimal in vivo efficacy.
Yinxing Miao +16 more
openaire +2 more sources
Covalent modification of cell membranes has shown promise for tumor imaging and therapy. However, existing membrane labeling techniques face challenges such as slow kinetics and poor selectivity for cancer cells, leading to off-target effects and suboptimal in vivo efficacy.
Yinxing Miao +16 more
openaire +2 more sources
Pretargeted Peptide Imaging and Therapy
Cancer Biotherapy and Radiopharmaceuticals, 1999D A, Goodwin, C F, Meares
openaire +2 more sources
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Jun J Mao,, Msce +2 more
exaly
Trans-cyclooctene modified antibodies for pretargeted imaging of amyloid-β
Nuclear Medicine and Biology, 2022Sara Lopes van den Broek +5 more
openaire +1 more source
Pretargeted PET imaging of trans-cyclooctene functionalized spherical nucleic acids
Nuclear Medicine and Biology, 2023Tatsiana Auchynnikava +8 more
openaire +1 more source
In Vivo Chemistry for Pretargeted Tumor Imaging in Live Mice
Angewandte Chemie International Edition, 2010Raffaella, Rossin +6 more
openaire +2 more sources
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Ca-A Cancer Journal for Clinicians, 2020Aaron J Grossberg +2 more
exaly
Oral complications of cancer and cancer therapy
Ca-A Cancer Journal for Clinicians, 2012Joel B Epstein +2 more
exaly